Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
Jacques Galipeau, Mauro Krampera, Katarina LeBlanc, et al.
Cytotherapy (2021) Vol. 23, Iss. 5, pp. 368-372
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Guido Moll, James A. Ankrum, Scott D. Olson, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 1, pp. 2-13
Open Access | Times Cited: 111
Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics
Chasen Cottle, Amanda Paige Porter, Ariel Joy Lipat, et al.
Current Stem Cell Reports (2022) Vol. 8, Iss. 2, pp. 72-92
Open Access | Times Cited: 86
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
Nadir Kadri, Sylvie Amu, Ellen Iacobaeus, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 6, pp. 613-625
Open Access | Times Cited: 51
Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine
Jhi Biau Foo, Qi Hao Looi, Pan Pan Chong, et al.
Stem Cells International (2021) Vol. 2021, pp. 1-30
Open Access | Times Cited: 80
Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review
An Duong, Gaganvir Parmar, Aidan M. Kirkham, et al.
Cytotherapy (2023) Vol. 25, Iss. 9, pp. 939-945
Closed Access | Times Cited: 36
Independent human mesenchymal stromal cell–derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model
Rabea J. Madel, Verena Börger, Robin Dittrich, et al.
Cytotherapy (2023) Vol. 25, Iss. 8, pp. 821-836
Open Access | Times Cited: 34
Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial
Ridhima Vij, Kevin A. Stebbings, Hosu Kim, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Dominique Farge, Séverine Loisel, Matthieu Resche‐Rigon, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 2, pp. e91-e104
Open Access | Times Cited: 24
Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges
Poonam Yadav, Sumeet Kumar Singh, Sonu Rajput, et al.
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108563-108563
Closed Access | Times Cited: 16
Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis
Séverine Loisel‐Meyer, Pauline Lansiaux, Delphine Rossille, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 4, pp. 194-206
Open Access | Times Cited: 15
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee
Kevin P. Robb, Jacques Galipeau, Yufang Shi, et al.
Cytotherapy (2023) Vol. 26, Iss. 5, pp. 413-417
Open Access | Times Cited: 14
EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro
Tobias Tertel, Robin Dittrich, Pierre Arsène, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles
Michel Bremer, Fabiola Nardi Bauer, Tobias Tertel, et al.
Cytotherapy (2023) Vol. 25, Iss. 8, pp. 847-857
Open Access | Times Cited: 13
First Clinical Experiences Using Preconditioning Approaches to Improve MSC-Based Therapies
Bryan Le, Amin Cressman, David L.S. Morales, et al.
Current Stem Cell Reports (2024) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 5
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options
Débora B. Mello, Fernanda Mesquita, Danúbia Silva dos Santos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6063-6063
Open Access | Times Cited: 5
Regenerative and translational medicine in COPD: hype and hope
Lucas Pires Guarnier, Lincoln Gozzi Moro, Francislaine Aparecida dos Reis Lívero, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 220223-220223
Open Access | Times Cited: 12
Acute respiratory distress vs healthy lung environments differently affect mesenchymal stromal cell extracellular vesicle miRNAs
Sara Rolandsson Enes, Irakli Dzneladze, Thomas H. Hampton, et al.
Cytotherapy (2025)
Closed Access
The Current State of Cytotherapy and the Field of Cell and Gene Therapy
William Ying Khee Hwang, Ezzah Mohamed Muzammil
Cytotherapy (2025)
Closed Access
Human Mesenchymal Stem Cell Therapy: Potential Advances for Reducing Cystic Fibrosis Infection and Organ Inflammation
Tracey L. Bonfield, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025) Vol. 38, Iss. 1, pp. 101602-101602
Closed Access
Putative critical quality attribute matrix identifies mesenchymal stromal cells with potent immunomodulatory and angiogenic “fitness” ranges in response to culture process parameters
Kevin P. Robb, Julie Audet, Rajiv Gandhi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease
Sandra Calcat-i-Cervera, Clara Sanz‐Nogués, Timothy O’Brien
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 22
Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells
Ariel Joy Lipat, Chasen Cottle, Bonnie M Pirlot, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 9, pp. 971-986
Open Access | Times Cited: 15
Perinatal derivatives: How to best validate their immunomodulatory functions
Andrea Papait, Antonietta Rosa Silini, Maria Gazouli, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 15
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes
Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, et al.
Cytotherapy (2023) Vol. 25, Iss. 8, pp. 803-807
Open Access | Times Cited: 9
Umbilical cord-derived mesenchymal stem cell sheets transplanted subcutaneously enhance cell retention and survival more than dissociated stem cell injections
Mitsuyoshi Nakao, Makoto Matsui, Kyung-Sook Kim, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top